These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 29061534)

  • 1. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
    Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
    Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
    Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT.
    Kawano Y; Takaue Y; Mimaya J; Horikoshi Y; Watanabe T; Abe T; Shimizu Y; Matsushita T; Kikuta A; Watanabe A; Iwai A; Ito E; Endo M; Kodani N; Ohta S; Gushi K; Azuma H; Etoh T; Okamoto Y; Amano K; Hattori H; Eguchi H; Kuroda Y
    Blood; 1998 Dec; 92(11):4040-6. PubMed ID: 9834207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT).
    Arpaci F; Dogru T; Ozturk B; Komurcu S; Ozet A; Yilmaz MI; Beyzadeoglu M; Turan M; Sengul A; Yalcin A
    Haematologia (Budap); 2002; 32(3):253-64. PubMed ID: 12611485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial.
    Faber E; Pytlík R; Slabý J; Zapletalová J; Kozák T; Raida L; Papajík T; Zikesová E; Maresová I; Hamouzová M; Indrák K; Trnený M
    Eur J Haematol; 2006 Dec; 77(6):493-500. PubMed ID: 17042769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
    Weisdorf DJ; Verfaillie CM; Davies SM; Filipovich AH; Wagner JE; Miller JS; Burroughs J; Ramsay NK; Kersey JH; McGlave PB
    Blood; 1995 Jun; 85(12):3452-6. PubMed ID: 7540062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed administration of filgrastim (G-CSF) following autologous peripheral blood stem cell transplantation (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G-CSF.
    Pai V; Fernandez SA; Laudick M; Rosselet R; Termuhlen A
    Pediatr Blood Cancer; 2010 May; 54(5):728-33. PubMed ID: 20063422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.
    Grosso D; Leiby B; Wilde L; Carabasi M; Filicko-O'Hara J; O'Hara W; Wagner JL; Mateja G; Alpdogan O; Binder A; Kasner M; Keiffer G; Klumpp T; Martinez UO; Palmisiano N; Porcu P; Gergis U; Flomenberg N
    Transplant Cell Ther; 2022 Dec; 28(12):831.e1-831.e7. PubMed ID: 36167307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation.
    de Azevedo AM; Nucci M; Maiolino A; Vigorito AC; Simões BP; Aranha FJ; Tabak DG; Voltarelli J; de Souza CA
    Bone Marrow Transplant; 2002 May; 29(9):745-51. PubMed ID: 12040471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
    Adkins DR; Goodnough LT; Shenoy S; Brown R; Moellering J; Khoury H; Vij R; DiPersio J
    Blood; 2000 Jun; 95(11):3605-12. PubMed ID: 10828051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.
    McQuaker IG; Hunter AE; Pacey S; Haynes AP; Iqbal A; Russell NH
    J Clin Oncol; 1997 Feb; 15(2):451-7. PubMed ID: 9053465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee SL; Finkelstein DM; Spitzer TR
    Bone Marrow Transplant; 1998 May; 21(10):1005-10. PubMed ID: 9632273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.
    Cox JE; Campos S; Wu J; May R; Liu H; Ramos CA; Carrum G; Heslop HE; Brenner MK; Kamble RT
    Bone Marrow Transplant; 2014 Feb; 49(2):219-22. PubMed ID: 24096822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
    Zumberg MS; Leather HL; Nejame C; Meyer C; Wingard JR
    Cytotherapy; 2002; 4(6):531-8. PubMed ID: 12568989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?
    Ener RA; Meglathery SB; Cuhaci B; Topolsky D; Styler MJ; Crilley P; Brodsky I; Kahn SB; King RS
    Am J Clin Oncol; 2001 Feb; 24(1):19-25. PubMed ID: 11232944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.